Your browser doesn't support javascript.
loading
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
Migliori, Giovanni Battista; Tiberi, Simon; Zumla, Alimuddin; Petersen, Eskild; Chakaya, Jeremiah Muhwa; Wejse, Christian; Muñoz Torrico, Marcela; Duarte, Raquel; Alffenaar, Jan Willem; Schaaf, H Simon; Marais, Ben J; Cirillo, Daniela Maria; Alagna, Riccardo; Rendon, Adrian; Pontali, Emanuele; Piubello, Alberto; Figueroa, José; Ferlazzo, Gabriella; García-Basteiro, Alberto; Centis, Rosella; Visca, Dina; D'Ambrosio, Lia; Sotgiu, Giovanni.
Afiliação
  • Migliori GB; Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Via Roncaccio 16, Tradate, Varese, 21049, Italy. Electronic address: giovannibattista.migliori@icsmaugeri.it.
  • Tiberi S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom. Electronic address: simon.tiberi@nhs.net.
  • Zumla A; Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom. Electronic address: a.i.zumla@gmail.com.
  • Petersen E; Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman; Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Denmark; ESCMID Emerging Infections Task Force, Basel, Switzerland. Electronic address: eskild.petersen@gmail.com.
  • Chakaya JM; The International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya. Electronic address: chakaya.jm@gmail.com.
  • Wejse C; Department of Infectious Disease, Aarhus University Hospital and School of Public Health, Faculty of Health Sciences, University of Aarhus, Denmark. Electronic address: wejse@dadlnet.dk.
  • Muñoz Torrico M; Clínica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias, Ciudad de México, Mexico. Electronic address: dra_munoz@hotmail.com.
  • Duarte R; National Reference Centre for MDR-TB, Hospital Centre Vila Nova de Gaia, Department of Pneumology, Public Health Science and Medical Education Department, Faculty of Medicine, University of Porto, Porto, Portugal. Electronic address: raquelafduarte@gmail.com.
  • Alffenaar JW; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Westmead Hospital, Sydney, Australia; Dept. Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: j.w.c.alffenaar@umcg.nl.
  • Schaaf HS; Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa. Electronic address: hss@sun.ac.za.
  • Marais BJ; The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia; The University of Sydney Marie Bashir Institute for Infectious Diseases and Biosecurity, Sydney, New South Wales, Australia. Electronic address: ben.marais@health.nsw.gov.au.
  • Cirillo DM; Emerging Pathogens Unit, TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Milan, Italy. Electronic address: cirillo.daniela@hsr.it.
  • Alagna R; Emerging Pathogens Unit, TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Milan, Italy. Electronic address: alagna.riccardo@hsr.it.
  • Rendon A; Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias CIPTIR, University Hospital of Monterrey UANL (Universidad Autonoma de Nuevo Leon), Monterrey, Mexico. Electronic address: adrianrendon@hotmail.com.
  • Pontali E; Department of Infectious Diseases, Galliera Hospital, Genova, Italy. Electronic address: pontals@yahoo.com.
  • Piubello A; The International Union Against Tuberculosis and Lung Disease, Paris, France; Tuberculosis Division, Damien Foundation, Niamey, Niger. Electronic address: albertopiubello@yahoo.it.
  • Figueroa J; National Health Service (NHS) England, London, United Kingdom. Electronic address: josefigueroa@doctors.org.uk.
  • Ferlazzo G; Southern Africa Medical Unit, Médecins Sans Frontières, Cape Town, South Africa. Electronic address: Gabriella.FERLAZZO@joburg.msf.org.
  • García-Basteiro A; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain. Electronic address: alberto.garcia-basteiro@manhica.net.
  • Centis R; Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Via Roncaccio 16, Tradate, Varese, 21049, Italy. Electronic address: rosella.centis@icsmaugeri.it.
  • Visca D; Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy; Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese, Italy. Electronic address: dina.visca@icsmaugeri.it.
  • D'Ambrosio L; Public Health Consulting Group, Lugano, Switzerland. Electronic address: liadambrosio59@gmail.com.
  • Sotgiu G; Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy. Electronic address: gsotgiu@uniss.it.
Int J Infect Dis ; 92S: S15-S25, 2020 Mar.
Article em En | MEDLINE | ID: mdl-32032752

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos Idioma: En Ano de publicação: 2020 Tipo de documento: Article